Abstract：
Multicancer early detection panels have recently become available to patients with a provider\'s prescription and an out-of-pocket fee. Beyond theoretical modeling, little is known about how these assays will impact primary care practices despite a high likelihood that primary care providers (PCPs) will be ordering these tests with some frequency. In particular, there are concerns about patient counseling, costs, frequency of testing, patient anxiety, and subsequent testing for a positive result. This review aims to appraise the current literature and provide a framework that PCPs can use to discuss these tests with patients and streamline their ordering, interpretation, and overall use into everyday practice.
摘要：
最近，具有提供者处方和自付费用的患者可以使用多发性癌症早期检测小组。除了理论建模之外，尽管初级保健提供者(PCP)很有可能以一定的频率订购这些检测,但人们对这些检测将如何影响初级保健实践知之甚少.特别是,有关于病人咨询的担忧，成本,测试频率，患者焦虑,以及随后的阳性结果测试。这篇综述旨在评估当前的文献，并提供一个PCP可以用来与患者讨论这些测试并简化其订购的框架。解释,并全面运用到日常实践中。
